NURS 1140 Pharmacology Final Exam EAQs 2026/2027 – 35+ Questions & Correct Answers | GI Drugs, PPIs, Antiulcer Therapy, Antiemetics & Nausea/Vomiting

This NURS 1140 Pharmacology Final Exam EAQs 2026/2027 study resource contains 35+ exam-style questions with supplied correct answers across 16 pages. It provides focused pharmacology review of gastrointestinal medications, proton pump inhibitors (PPIs), H2-receptor antagonists, antacids, antiulcer agents, prokinetic medications, antiemetics, nausea and vomiting, GERD, peptic ulcer disease, H. pylori treatment, chemotherapy-induced nausea and vomiting, and clinically important drug interactions. The document uses multiple-choice, select-all-that-apply, sequencing, medication-safety, and patient-care questions to reinforce drug classes, indications, adverse effects, interactions, monitoring, and nursing considerations. The first major section focuses on acid-related gastrointestinal disorders and antiulcer pharmacology. Questions review the role of proton pump inhibitors with antimicrobial therapy for Helicobacter pylori, H2-receptor antagonists such as cimetidine, famotidine, and nizatidine, and PPIs including esomeprazole, pantoprazole, dexlansoprazole, lansoprazole, and omeprazole. The material also covers Zollinger-Ellison syndrome, GERD, peptic ulcer disease, intermittent heartburn, gastric acid suppression, and individualized medication scheduling to minimize drug interactions. Medication-specific questions examine misoprostol, sucralfate, metoclopramide, and antacids. The source associates misoprostol with reducing NSAID-induced ulcers and reviews sucralfate as an option for patients unable to tolerate other antiulcer therapy. Metoclopramide is examined as a prokinetic agent in diabetic gastroparesis and reflux esophagitis. Students also review renal-function assessment before magnesium-containing OTC antacids and management of the unpleasant chalky taste associated with some antacid tablets. A substantial portion is devoted to antiemetic pharmacology and the physiology of nausea and vomiting. The resource covers phenothiazines, dopamine antagonists, serotonin antagonists, antihistamines, anticholinergic effects, cannabinoids, and neurokinin-1-related therapy. Specific medications include haloperidol, ondansetron, granisetron, aprepitant, meclizine, dronabinol, apomorphine, and promethazine. Students also review the chemoreceptor trigger zone, vomiting center, labyrinth stimulation, retching, hydration assessment, abdominal assessment, and the sequence of physiologic events occurring during vomiting. The exam material differentiates several clinically relevant forms of nausea and vomiting, including motion sickness, morning sickness/hyperemesis gravidarum, postoperative nausea and vomiting (PONV), chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), psychogenic vomiting, and anticipatory nausea and vomiting. The source identifies antihistamines for motion sickness and discusses ondansetron in CINV, PONV, and RINV. It also emphasizes the principle that antiemetics can be more effective when administered before nausea begins. Drug safety and interactions are another important theme. Students review cimetidine-associated breast soreness and gynecomastia, famotidine-associated dizziness, phenytoin-related concerns with PPIs, aprepitant and warfarin monitoring using INR, and long-term high-dose omeprazole considerations. The source specifically asks about increased fracture risk with prolonged high-dose omeprazole therapy and highlights the need to monitor medication interactions when treating GERD and peptic ulcer disease. Relevant students: This document is particularly relevant to NURS 1140 students, Pharmacology students, BSN and ADN nursing students, practical nursing students, pre-licensure nursing students, and learners preparing for pharmacology or NCLEX-style medication questions. It is especially useful for students reviewing gastrointestinal pharmacology, antiulcer medications, PPIs, H2 blockers, antiemetics, nausea and vomiting, drug interactions, adverse effects, and medication-safety principles. The uploaded document identifies the course as NURS 1140 but does not specify a university, so a university name should not be invented. Keywords: NURS 1140 Pharmacology Final Exam, NURS 1140 Final Exam 2026, NURS 1140 Final Exam 2027, NURS 1140 EAQs, NURS 1140 questions and answers, NURS 1140 study guide, pharmacology final exam, pharmacology exam questions, nursing pharmacology questions, gastrointestinal pharmacology, GI medications, proton pump inhibitors, PPI pharmacology, H2 receptor antagonists, antiulcer medications, Helicobacter pylori treatment, GERD pharmacology, peptic ulcer disease, Zollinger Ellison syndrome, omeprazole, pantoprazole, esomeprazole, dexlansoprazole, lansoprazole, cimetidine, famotidine, misoprostol, sucralfate, metoclopramide, antacids, antiemetic pharmacology, nausea and vomiting, chemotherapy induced nausea and vomiting, CINV, postoperative nausea and vomiting, PONV, ondansetron, granisetron, aprepitant, meclizine, haloperidol, serotonin antagonists, dopamine antagonists, motion sickness, diabetic gastroparesis, warfarin INR monitoring, nursing pharmacology study guide